How Participants Perceive Biomedical Research in Pulmonology (PROTOACCEPT2)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03397056|
Recruitment Status : Recruiting
First Posted : January 11, 2018
Last Update Posted : September 13, 2019
|Condition or disease||Intervention/treatment|
|Biomedical Research||Other: Questionnaire|
Over time, clinical research has become a challenge both in terms of public health and in terms of scientific progress. Additionally, it has also become a financial challenge for institutions, especially in France where a significant part of their government funding is provided according to their ability to conduct quality clinical research. Pulmonology is a sector where clinical research is well established with strong incentives from several pharmaceutical companies and numerous academic research projects. Nevertheless, it is important to put the patient back at the centre of biomedical research.
A better knowledge of patient expectations, questions and misunderstandings would considerably improve treatment observance, clinical trial data quality, doctor-patient trust/relationship, and ultimately, the patient's health.
The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.
The secondary objectives are to determine:
- how biomedical research is experienced / felt;
- if the information delivered to the patient (orally - information note) is clearly perceived.
Comparisons with PROTOACCEPT1 (osf.io/nsjjr) will also be performed.
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||How Participants Perceive Biomedical Research in Pulmonology|
|Actual Study Start Date :||March 7, 2018|
|Estimated Primary Completion Date :||December 31, 2019|
|Estimated Study Completion Date :||December 31, 2019|
The study population
The target population corresponds to patients with a respiratory disease already included in a biomedical research protocol.
The Questionnaire is provided in the links at the end of the declaration.
- The PROTOACCEPT2 questionnaire. [ Time Frame: day 0 (transversal study) ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03397056
|Contact: Arnaud Bourdin, MD,PhDemail@example.com|
|APHM - Hôpital Nord||Recruiting|
|Marseille, France, 13915|
|Principal Investigator: Pascal Chanez, MD, PhD|
|CHRU Montpellier - Hôpital Arnaud de Villeneuve||Recruiting|
|Montpellier, France, 34295|
|Principal Investigator: Arnaud Bourdin, MD, PhD|
|Study Director:||Arnaud Bourdin, MD, PhD||University Hospitals of Montpellier|